Back to 
Quadrature Capital Ltd
Quadrature Capital Ltd
CRDL
2 quarters
Position history for Quadrature Capital Ltd's holdings in Cardiol Therapeutics Inc.
Yes. Quadrature Capital holds 30,566 shares of CRDL (Cardiol Therapeutics), worth $32,400, as of its Q2 2026 13F filing. It reduced the position by 17,321 shares (-36.2%) from Q1 2026. Quadrature Capital has held CRDL since Q1 2026, across 2 quarterly 13F filings.
Current Value
$32,400
Current Shares
30,566
Total Value Change
-$32,247
Total Shares Change
-17,321
Quarter-by-Quarter History
Other major holders of CRDL: Mirae Asset Global Investments Co., Ltd., Citadel Advisors LLC